Search results
Results From The WOW.Com Content Network
AstraZeneca ditches £450m investment in UK plant January 31, 2025 at 10:39 AM AstraZeneca has scrapped plans to invest £450m in expanding a vaccine manufacturing plant in Liverpool, blaming a ...
The AstraZeneca R&D facility in Mölndal near Gothenburg, Sweden The new AstraZeneca Corporate HQ under construction in Cambridge, United Kingdom. AstraZeneca develops, manufactures and sells pharmaceutical and biotechnology products to treat disorders in the oncology, cardiovascular, gastrointestinal, infection, neuroscience, respiratory and ...
Note: the activities of the parent companies of many of the companies listed below are not restricted solely to the United Kingdom. For example, AstraZeneca and GlaxoSmithKline, although headquartered in the United Kingdom, have activities in numerous other countries, and Johnson & Johnson and Pfizer are both headquartered in the United States ...
The UK is home to GlaxoSmithKline and AstraZeneca, respectively the world's fifth- and sixth-largest pharmaceutical companies measured by 2009 market share. [8] It is also home to the multinational Hikma Pharmaceuticals. Foreign companies with a major presence in the UK pharmaceutical industry include Pfizer, Novartis, [9] Hoffmann–La Roche ...
The Financial Times leads with the news that pharmaceutical giant AstraZeneca has cancelled a £450m manufacturing plant in the UK after "months of wrangling over state support for the project".
British finance minister Rachel Reeves wants to reduce state provisions to the company's vaccine centre, which will cut the pledge made by the previous administration from about 90 million pounds ...
Li Ka Shing Centre of the Cancer Research UK Cambridge Institute. The Cancer Research UK Cambridge Institute is one of four core funded Cancer Research UK Institutes [11] and a department of the University of Cambridge. In 2018, the department received an annual budget of £45 million, £27.8 million of which came from Cancer Research UK.
Around two million doses of AstraZeneca and Oxford University's COVID-19 vaccine are set to be supplied every week by the middle of January in the UK, according to The Times newspaper. Britain ...